Anna Lechner

Title: Anna Lechner: Innovator in Prenyltransferase Variants

Introduction

Anna Lechner is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biochemistry, particularly in the development of prenyltransferase variants. Her work focuses on enhancing the production of prenylated aromatic compounds, which have important applications in therapeutic compositions.

Latest Patents

Anna Lechner holds a patent for "Prenyltransferase variants and methods for production of prenylated aromatic compounds." This patent describes prenyltransferases, including non-natural variants that possess at least one amino acid substitution compared to their natural counterparts. These variants are capable of achieving at least a two-fold greater rate of formation of cannabinoids, such as cannabigerolic acid and cannabigerol, compared to wild type controls. The variants also demonstrate regioselectivity towards desired cannabinoid isomers, which can be utilized in engineered microbes to produce valuable compounds.

Career Highlights

Anna Lechner is currently employed at Genomatica, Inc., where she continues to advance her research in the field of biochemistry. Her innovative work has positioned her as a key figure in the development of cannabinoid production methods.

Collaborations

Throughout her career, Anna has collaborated with notable colleagues, including Kevin G Hoff and Michael A Noble. These partnerships have further enhanced her research and contributed to the advancement of her projects.

Conclusion

Anna Lechner is a trailblazer in the field of prenyltransferase research, with a focus on cannabinoid production. Her innovative patents and collaborations highlight her significant contributions to biochemistry and therapeutic applications.